(ISMRM 2024) <sup>129</sup>Xe HyperCEST Imaging of a Novel R3-Noria-methanesulfonate Supramolecular Cage using a 3.0 T Clinical MRI
Meeting Banner
Abstract #3199

129Xe HyperCEST Imaging of a Novel R3-Noria-methanesulfonate Supramolecular Cage using a 3.0 T Clinical MRI

Viktoriia Batarchuk1,2, Yurii Shepelytskyi1,2, Vira Grynko2,3, Antal Halen Kovacs4, Aaron Hodgson5, Karla Rodriguez1, Ruba Aldossary2, Tanu Talwar1, Carson Hasselbrink6, Brenton DeBoef7, and Mitchell S. Albert1,2,8
1Chemistry, Lakehead University, Thunder Bay, ON, Canada, 2Thunder Bay Regional Health Research Institute, Thunder Bay, ON, Canada, 3Chemistry and Materials Science Program, Lakehead University, Thunder Bay, ON, Canada, 4Applied Life Science Program, Lakehead University, Thunder Bay, ON, Canada, 5Physics Program, Lakehead University, Thunder Bay, ON, Canada, 6California Polytechnic State University, San Luis Obispo, CA, United States, 7University of Rhode Island, Kingston, RI, United States, 8Northern Ontario School of Medicine, Thunder Bay, ON, Canada

Synopsis

Keywords: Hyperpolarized MR (Gas), Hyperpolarized MR (Gas), xenon-129, HyperCEST, chemical exchange, Noria, R3-Noria-methanesulfonate

Motivation: In the setting of molecular MRI, designing a contrast agent that can be applied in clinical studies and which offers high sensitivity poses a significant challenge.

Goal(s): We aimed to demonstrate a novel water-soluble R3-Noria-MeSO3H macrocycle as a viable supramolecular cage agent for 129Xe molecular imaging.

Approach: Hyperpolarized 129Xe chemical exchange saturation transfer MR imaging and spectroscopy were conducted in vitro using a 3.0T clinical MRI scanner.

Results: We demonstrated that R3-Noria-MeSO3H produces a superior HyperCEST effect and investigated its dependence on concentrations in various aqueous solutions.

Impact: The introduction of the novel R3-Noria-MeSO3H macrocycle for HP 129Xe HyperCEST imaging marks a critical milestone, establishing a new frontier in 129Xe molecular imaging with heightened sensitivity and potential for advancing clinical applications in diagnostic precision and therapeutic monitoring.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords

noriamesosalinedepletionmoleculardepolarizationxenonclinicalthunderconcentrationchemical